EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats

Hongxing Zheng, Wenrui Yan, Mengli Shao, Shanshan Qi

Molecules · 2024

DOI: 10.3390/molecules29050924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hongxing Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong 723000, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Bone Diseases, Metabolic, Osteoporosis, Picolinic Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: project from Qinba State Key Laboratory of Biological Re-sources and Eco-Environment, Science and Technology Department of Shaanxi Province Scientists + Engineers Team Construction Project, Project of Shaanxi Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic osteoporosis (DOP) is an abnormal metabolic disease caused by long-term hyperglycemia. In this study, a model rat of streptozotocin (STZ)-induced diabetes was established, and chromium picolinate (5 mg·kg−1) was given; the changes in blood glucose and body weight were detected before and after administration; and bone mineral density (BMD), bone morphology, bone turnover markers, inflammatory cytokines, and oxidative stress indicators were observed in each group. We found that after chromium picolinate (CP) intervention for 8 weeks, the blood glucose level was decreased; the BMD, the bone histomorphology parameters, and the pathological structure were improved; the expression of bone resorption-related proteins was downregulated; and the expression of bone formation-related proteins was upregulated. Meanwhile, serum antioxidant activity was increased, and inflammatory cytokine levels were decreased. In conclusion, CP could alleviate DOP by anti-oxidation, inhibition of bone turnover, anti-inflammation, and regulation of the OPG/RANKL/RANK signaling pathway. Therefore, CP has important application values for further development as a functional food or active medicine in DOP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalBone Diseases, MetabolicOsteoporosisPicolinic AcidsRatsAnimalsBlood GlucoseBone DensityRANK Ligand

Stichwörter der Autor:innen

bone metabolismbone microstructurebone transformationchromium picolinatediabetic osteoporosis

Substanzen

Blood Glucosepicolinic acidRANK LigandPicolinic Acids

Autor:innen und Institutionen

  • School of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong 723000, China.
  • State Key Laboratory of Qinba Biological Resources and Ecological Environment, Hanzhong 723000, China.
  • Shaanxi Black Organic Food Engineering Technology Research Center, Hanzhong 723000, China.
  • Qinba Mountain Area Collaborative Innovation Center of Bioresources Comprehensive Development, Hanzhong 723000, China.
  • Shaanxi Provincial Key Laboratory of Resource Biology, Hanzhong 723001, China.
  • Shaanxi Migukang Biotechnology Company, Xi'an 710018, China.

Förderung

  • project from Qinba State Key Laboratory of Biological Re-sources and Eco-Environment
  • Science and Technology Department of Shaanxi Province Scientists + Engineers Team Construction Project
  • Project of Shaanxi Provincial Department of Science and Technology
  • Key Research and Development Project of Shaanxi Province
  • Young Talent Fund of Association for Science and Technology in Shaanxi
  • Qinba State Key Laboratory of Biological Re-sources and Eco-Environment
  • Shaanxi Provincial Department of Science and Technology
  • Shaanxi Provincial Department of Education Service Local Special Project

Zitieren

APA

Zheng, H., Yan, W., Shao, M., & Qi, S. (2024). Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats. Molecules. https://doi.org/10.3390/molecules29050924

Vancouver

Zheng H, Yan W, Shao M, Qi S. Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats. Molecules. 2024. doi:10.3390/molecules29050924

BibTeX
@article{Zheng2024,
  author = {Zheng, Hongxing and Yan, Wenrui and Shao, Mengli and Qi, Shanshan},
  title = {Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29050924}
}
Kostenlos starten →